Benjamin Eckhardt

1.3k total citations · 1 hit paper
32 papers, 779 citations indexed

About

Benjamin Eckhardt is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Benjamin Eckhardt has authored 32 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 21 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Benjamin Eckhardt's work include Hepatitis C virus research (21 papers), HIV, Drug Use, Sexual Risk (19 papers) and Hepatitis B Virus Studies (12 papers). Benjamin Eckhardt is often cited by papers focused on Hepatitis C virus research (21 papers), HIV, Drug Use, Sexual Risk (19 papers) and Hepatitis B Virus Studies (12 papers). Benjamin Eckhardt collaborates with scholars based in United States and Canada. Benjamin Eckhardt's co-authors include Brian R. Edlin, Marla A. Shu, Scott D. Holmberg, Tracy Swan, Kristen Marks, Shashi N. Kapadia, Pedro Mateu‐Gelabert, Chunki Fong, Yesenia Aponte-Meléndez and Judith A. Aberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Benjamin Eckhardt

32 papers receiving 759 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

2015 330 citations Brian R. Edlin, Benjamin Eckhardt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Eckhardt United States	14	586	522	194	79	65	32	779
Amanda Yu Canada	22	1.0k 1.8×	912 1.7×	177 0.9×	112 1.4×	34 0.5×	67	1.3k
Carolyn Wester United States	11	667 1.1×	715 1.4×	159 0.8×	72 0.9×	22 0.3×	25	869
Carmine Rossi United States	16	487 0.8×	453 0.9×	194 1.0×	42 0.5×	109 1.7×	85	846
Tracy Swan United States	16	1.2k 2.0×	1.2k 2.4×	341 1.8×	49 0.6×	27 0.4×	31	1.5k
Sofia Bartlett Canada	15	519 0.9×	447 0.9×	161 0.8×	99 1.3×	27 0.4×	58	731
Jennifer H MacLachlan Australia	15	795 1.4×	564 1.1×	214 1.1×	41 0.5×	19 0.3×	42	981
Ivana Carey United Kingdom	21	903 1.5×	843 1.6×	205 1.1×	131 1.7×	18 0.3×	65	1.3k
Asgeir Johannessen Norway	16	418 0.7×	246 0.5×	455 2.3×	37 0.5×	148 2.3×	55	902
Ravi Kavasery United States	8	484 0.8×	301 0.6×	280 1.4×	39 0.5×	25 0.4×	8	599
Sheila Cameron United Kingdom	13	580 1.0×	452 0.9×	155 0.8×	100 1.3×	13 0.2×	21	676

Countries citing papers authored by Benjamin Eckhardt

Since Specialization

Citations

This map shows the geographic impact of Benjamin Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Eckhardt more than expected).

Fields of papers citing papers by Benjamin Eckhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Eckhardt. The network helps show where Benjamin Eckhardt may publish in the future.

Co-authorship network of co-authors of Benjamin Eckhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Eckhardt. A scholar is included among the top collaborators of Benjamin Eckhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Eckhardt. Benjamin Eckhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Finbråten, Ane‐Kristine, et al.. (2025). Providers’ Perspectives on Implementation of Low-threshold HCV Treatment in New York State: A Qualitative Study. Open Forum Infectious Diseases. 12(4). ofaf184–ofaf184. 1 indexed citations

Aponte-Meléndez, Yesenia, et al.. (2024). Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico. Journal of Substance Use and Addiction Treatment. 160. 209308–209308. 1 indexed citations

Mateu‐Gelabert, Pedro, Chunki Fong, Shashi N. Kapadia, et al.. (2024). Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model. PLoS ONE. 19(8). e0308102–e0308102. 1 indexed citations

Aponte-Meléndez, Yesenia, et al.. (2023). Hepatitis C virus care cascade among people who inject drugs in Puerto Rico: Minimal HCV treatment and substantial barriers to HCV care. SHILAP Revista de lepidopterología. 8. 100178–100178. 2 indexed citations

Mateu‐Gelabert, Pedro, Nasim S. Sabounchi, Honoria Guarino, et al.. (2022). Hepatitis C virus risk among young people who inject drugs. Frontiers in Public Health. 10. 835836–835836. 15 indexed citations

Mateu‐Gelabert, Pedro, et al.. (2022). Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study. Journal of Addiction Medicine. 17(3). e202–e205. 2 indexed citations

Kapadia, Shashi N., Benjamin Eckhardt, Jared A. Leff, et al.. (2022). Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial. SHILAP Revista de lepidopterología. 5. 100109–100109. 1 indexed citations

Mateu‐Gelabert, Pedro, et al.. (2022). Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage. Harm Reduction Journal. 19(1). 41–41. 18 indexed citations

Aponte-Meléndez, Yesenia, Pedro Mateu‐Gelabert, Chunki Fong, et al.. (2021). The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduction Journal. 18(1). 118–118. 42 indexed citations

10.

Fong, Chunki, Pedro Mateu‐Gelabert, Benjamin Eckhardt, et al.. (2021). Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug and Alcohol Dependence. 221. 108589–108589. 20 indexed citations

11.

Eckhardt, Benjamin, Shashi N. Kapadia, Melinda Smith, et al.. (2021). 911. Rapid Hepatitis C Treatment Initiation in Young People Who Inject Drugs: Final Results from the HCV-Seek, Test and Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial. Open Forum Infectious Diseases. 8(Supplement_1). S547–S547. 1 indexed citations

12.

Filardo, Thomas D., Maria R. Khan, Noa Krawczyk, et al.. (2020). Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020). PLoS ONE. 15(11). e0242760–e0242760. 30 indexed citations

13.

Akiyama, Matthew J., Ross MacDonald, Alison O. Jordan, et al.. (2019). Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial. BMC Infectious Diseases. 19(1). 703–703. 38 indexed citations

14.

Mateu‐Gelabert, Pedro, et al.. (2019). Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination. International Journal of Drug Policy. 72. 33–39. 15 indexed citations

15.

Eckhardt, Benjamin, et al.. (2018). Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program. Open Forum Infectious Diseases. 5(4). ofy048–ofy048. 42 indexed citations

16.

Akiyama, Matthew J., Ashly E. Jordan, J Schwartz, et al.. (2018). Linkage to HCV care and reincarceration following release from New York City jails. Journal of Hepatology. 68. S175–S176. 3 indexed citations

17.

Eckhardt, Benjamin, Marla A. Shu, Courtney McKnight, et al.. (2017). Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. PLoS ONE. 12(5). e0177341–e0177341. 48 indexed citations

18.

Eckhardt, Benjamin, et al.. (2012). Glycated Hemoglobin A _1c as Screening for Diabetes Mellitus in HIV-Infected Individuals. AIDS Patient Care and STDs. 26(4). 197–201. 40 indexed citations

19.

Eckhardt, Benjamin, et al.. (2012). Hyperparathyroidism and Complications Associated with Vitamin D Deficiency in HIV-Infected Adults in New York City, New York. AIDS Research and Human Retroviruses. 28(9). 1025–1032. 15 indexed citations

20.

Eckhardt, Benjamin & Marshall J. Glesby. (2008). Antiretroviral therapy and cardiovascular risk: are some medications cardioprotective?. Current Opinion in HIV and AIDS. 3(3). 226–233. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact